Industry Corner Live With AngioDynamics CEO Jim Clemmer

IEEE Pulse. 2025 Nov-Dec;16(6):71-74. doi: 10.1109/MPULS.2025.3640869.ABSTRACTJim Clemmer, CEO of AngioDynamics, shares how he transformed the company into a science-driven innovator focused on cancer and cardiovascular disease through bold portfolio changes, deep physician engagement, and a strong

C Chad Andresen

Trehalose: A Promising Therapeutic Agent for Diverse Pathological Conditions

Curr Med Sci. 2026 Mar 6. doi: 10.1007/s11596-026-00174-z. Online ahead of print.ABSTRACTTrehalose, a naturally occurring disaccharide, is gaining recognition for its therapeutic potential across a wide range of disorders. This review highlights the increasing importance of trehalose in clinical res

M Mahboobeh Ghasemzadeh Rahbardar